Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1988 | 12-1987 | 09-1987 | 12-1986 | 12-1985 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,151 | 15,855 | 16,291 | 4,533 | 1,983 |
| Receivables | 268 | 275 | 70 | 71 | 74 |
| Inventories | 75 | 45 | 136 | 129 | 13 |
| Other current assets | 536 | 354 | 435 | 96 | 19 |
| TOTAL | $16,030 | $16,529 | $16,931 | $4,829 | $2,089 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,363 | N/A | N/A | N/A |
| Other Non-Current Assets | 283 | 285 | 287 | 312 | 25 |
| TOTAL | $283 | $5,648 | $287 | $312 | $25 |
| Total Assets | $20,436 | $20,970 | $21,525 | $9,614 | $2,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 95 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 241 | 444 | 294 | 420 | 227 |
| Accrued Expenses | 0 | 112 | 0 | 78 | 18 |
| Other current liabilities | 209 | 22 | 69 | 0 | 630 |
| TOTAL | $545 | $673 | $422 | $582 | $884 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,046 | 3,000 | 3,352 | 3,335 | 0 |
| TOTAL | $3,046 | $3,056 | $3,352 | $3,439 | $14 |
| Total Liabilities | $3,591 | $3,729 | $3,774 | $4,021 | $898 |
| Shareholders' Equity | |||||
| Common Shares | 27,095 | 87 | 26,662 | 730 | 419 |
| Retained earnings | -10,250 | -9,707 | -8,911 | -5,866 | -2,726 |
| Other shareholders' equity | 0 | 33 | 0 | 10,729 | 4,160 |
| TOTAL | $16,845 | $17,241 | $17,751 | $5,592 | $1,854 |
| Total Liabilities And Equity | $20,436 | $20,970 | $21,525 | $9,614 | $2,751 |